Escherichia Coli.
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra.
Greater than 95.0% as determined by SDS-PAGE.
Interleukin-4 Porcine Recombinant produced in E. coli is a non-glycosylated monomer chain containing 110 amino acids and having a molecular mass of 12.7kDa.
IL-4 is purified by proprietary chromatographic techniques.
BCGF, BCDF, B cell stimulating factor, BSF-1, Lymphocyte stimulatory factor 1, IL-4, MGC79402, Binetrakin, Pitrakinra.
Escherichia Coli.
MHKCDITLQE IIKTLNILTA RKNSCMELPV TDVFAAPENT TEKETFCRAS TVLRHIYRHH TCMKSLLSGL DRNLSSMANM TCSVHEAKKS TLKDFLERLK TIMKEKYSKC.
Porcine Interleukin-4 (pIL-4) shares similar functions with its human counterpart. It is involved in the immune response regulation in pigs, making it a significant molecule in veterinary immunology. The recombinant form of pIL-4 is produced using genetic engineering techniques, where the pIL-4 gene is inserted into an expression vector and introduced into a host cell to produce the protein in large quantities .
Recombinant pIL-4 has been used in various research studies to understand its role in immune responses and its potential as an immunological adjuvant. For instance, a study involving a recombinant Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) expressing pIL-4 demonstrated that the recombinant virus induced higher levels of IL-4 in the blood and increased the percentage of double positive T cells (CD4+CD8+) in vaccinated pigs . This indicates that pIL-4 can enhance the immune response, although it did not significantly improve the protection efficacy of the PRRSV vaccine .
The production of recombinant pIL-4 involves several steps: